Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ERBB3 |
| Variant | K279N |
| Impact List | missense |
| Protein Effect | gain of function - predicted |
| Gene Variant Descriptions | ERBB3 (HER3) K279N lies within the extracellular domain of the Erbb3 (Her3) protein (UniProt.org). K279N results in increased focus formation compared to wild-type Erbb3 (Her3) when individually expressed and increased IL3-independent growth upon co-expression with ERBB2 (HER2) V956R, an impaired activator of homodimerization, in culture (PMID: 38806620), and therefore, is predicted to lead to a gain of Erbb3 (Her3) protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
ERBB3 mutant ERBB3 act mut ERBB3 K279N |
| Transcript | NM_001982.4 |
| gDNA | chr12:g.56088125G>C |
| cDNA | c.837G>C |
| Protein | p.K279N |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001982.4 | chr12:g.56088125G>C | c.837G>C | p.K279N | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|